Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses

被引:0
作者
Kyriakoulis, Konstantinos G. [1 ]
Kyriakoulis, Ioannis G. [1 ]
Trontzas, Ioannis P. [1 ]
Syrigos, Nikolaos [1 ]
Kyprianou, Ioanna A. [1 ]
Fyta, Eleni [1 ]
Kollias, Anastasios [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Sotiria Hosp, Sch Med, Dept Med 3, Athens 11527, Greece
关键词
COVID-19; cardiac injury; prognosis; mortality; meta-analysis; CORONAVIRUS DISEASE 2019; MYOCARDIAL INJURY; RISK-FACTORS; PROGNOSTIC VALUE; MORTALITY; BIOMARKERS; SEVERITY; COMPLICATIONS; PREVALENCE; IMPACT;
D O I
10.31083/j.rcm2312404
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cardiac injury (CI) is not a rare condition among hospitalized patients with coronavirus disease 2019 (COVID-19). Its prognostic value has been extensively reported through the literature, mainly in the context of observational studies. An impressive number of relevant meta-analyses has been conducted. These meta-analyses present similar and consistent results; yet interesting methodological issues emerge. Methods: A systematic literature search was conducted aiming to identify all relevant meta-analyses on (i) the incidence, and (ii) the prognostic value of CI among hospitalized patients with COVID-19. Results: Among 118 articles initially retrieved, 73 fulfilled the inclusion criteria and were included in the systematic review. Various criteria were used for CI definition mainly based on elevated cardiac biomarkers levels. The most frequently used biomarker was troponin. 30 meta-analyses reported the pooled incidence of CI in hospitalized patients with COVID-19 that varies from 5% to 37%. 32 meta-analyses reported on the association of CI with COVID-19 infection severity, with only 6 of them failing to show a statistically significant association. Finally, 46 meta-analyses investigated the association of CI with mortality and showed that patients with COVID-19 with CI had increased risk for worse prognosis. Four meta-analyses reported pooled adjusted hazard ratios for death in patients with COVID-19 and CI vs those without CI ranging from 1.5 to 3. Conclusions: The impact of CI on the prognosis of hospitalized patients with COVID-19 has gained great interest during the pandemic. Methodological issues such as the inclusion of not peer-reviewed studies, the inclusion of potentially overlapping populations or the inclusion of studies with unadjusted analyses for confounders should be taken into consideration. Despite these limitations, the adverse prognosis of patients with COVID-19 and CI has been consistently demonstrated.
引用
收藏
页数:13
相关论文
共 85 条
  • [1] Global burden of acute myocardial injury associated with COVID-19: A systematic review, meta-analysis, and meta-regression
    Abate, Semagn Mekonnen
    Mantefardo, Bahiru
    Nega, Solomon
    Chekole, Yigrem Ali
    Basu, Bivash
    Ali, Siraj Ahmed
    Taddesse, Moges
    [J]. ANNALS OF MEDICINE AND SURGERY, 2021, 68
  • [2] Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: An insight from a meta-analysis
    Aikawa, Tadao
    Takagi, Hisato
    Ishikawa, Kiyotake
    Kuno, Toshiki
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 51 - 55
  • [3] Cardiac Injury Biomarkers and the Risk of Death in Patients with COVID-19: A Systematic Review and Meta-Analysis
    Alzahrani, Sami H.
    Al-Rabia, Mohammed W.
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
  • [4] Cardiac biomarkers and COVID-19: A systematic review and meta-analysis
    An, Wen
    Kang, Ju-Seop
    Wang, Qiuyang
    Kim, Tae-Eun
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (09) : 1191 - 1197
  • [5] European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis The Task Force for the management of COVID-19 of the European Society of Cardiology
    Baigent, Colin
    Windecker, Stephan
    Andreini, Daniele
    Arbelo, Elena
    Barbato, Emanuele
    Bartorelli, Antonio L.
    Baumbach, Andreas
    Behr, Elijah R.
    Berti, Sergio
    Bueno, Hector
    Capodanno, Davide
    Cappato, Riccardo
    Chieffo, Alaide
    Collet, Jean-Philippe
    Cuisset, Thomas
    de Simone, Giovanni
    Delgado, Victoria
    Dendale, Paul
    Dudek, Dariusz
    Edvardsen, Thor
    Elvan, Arif
    Gonzalez-Juanatey, Jose R.
    Gori, Mauro
    Grobbee, Diederick
    Guzik, Tomasz J.
    Halvorsen, Sigrun
    Haude, Michael
    Heidbuchel, Hein
    Hindricks, Gerhard
    Ibanez, Borja
    Karam, Nicole
    Katus, Hugo
    Klok, Fredrikus A.
    Konstantinides, Stavros, V
    Landmesser, Ulf
    Leclercq, Christophe
    Leonardi, Sergio
    Lettino, Maddalena
    Marenzi, Giancarlo
    Mauri, Josepa
    Metra, Marco
    Morici, Nuccia
    Mueller, Christian
    Petronio, Anna Sonia
    Polovina, Marija M.
    Potpara, Tatjana
    Praz, Fabien
    Prendergast, Bernard
    Prescott, Eva
    Price, Susanna
    [J]. EUROPEAN HEART JOURNAL, 2022, 43 (11) : 1033 - 1058
  • [6] Meta-analysis Comparing Outcomes in Patients With and Without Cardiac Injury and Coronavirus Disease 2019 (COVID 19)
    Bansal, Agam
    Kumar, Ashish
    Patel, Divyang
    Puri, Rishi
    Kalra, Ankur
    Kapadia, Samir R.
    Reed, Grant W.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 140 - 146
  • [7] Systematic review and meta-analysis on coronary calcifications in COVID-19
    Cereda, A.
    Allievi, L.
    Palmisano, A.
    Tumminello, G.
    Barbieri, L.
    Mangieri, A.
    Laricchia, A.
    Khokhar, A.
    Giannini, F.
    Toselli, M.
    Sangiorgi, G. M.
    Esposito, A.
    Aseni, P.
    Lucreziotti, S.
    Mafrici, A.
    Carugo, S.
    [J]. EMERGENCY RADIOLOGY, 2022, 29 (04) : 631 - 643
  • [8] Myocardial injury in hospitalized COVID-19 patients: a retrospective study, systematic review, and meta-analysis
    Changal, Khalid
    Veria, Spiro
    Mack, Sean
    Paternite, David
    Sheikh, Shoaib Altaf
    Patel, Mitra
    Mir, Tanveer
    Sheikh, Mujeeb
    Ramanathan, P. Kasi
    [J]. BMC CARDIOVASCULAR DISORDERS, 2021, 21 (01)
  • [9] High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19
    Chapman, Andrew R.
    Bularga, Anda
    Mills, Nicholas L.
    [J]. CIRCULATION, 2020, 141 (22) : 1733 - 1735
  • [10] Chaudhary Rahul, 2021, Mayo Clin Proc Innov Qual Outcomes, V5, P388, DOI 10.1016/j.mayocpiqo.2021.01.009